Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

Explore the benefits and side effects of popular weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Learn how ...

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content ...

As Ozempic and other drugs used for weight loss continue to soar in popularity, the U.S. Food and Drug Administration (FDA) has issued a new warning for consumers. On Thursday, the FDA announced it ...

Use of the diabetes drug Ozempic for weight loss is rising. Understand the research, how it works, who should use it, and ...

GLP-1 drugs like Ozempic are a popular choice when it comes to losing weight, but they can have a steep cost, which West Virginian's seem willing to pay.

Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly ...